Therapeutic and inducing effect of corneal crosslinking on infectious keratitis
Author:
Corresponding Author:

Guo-Ying Mu. Department of Ophthalmology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan 250000, Shandong Province, China. mgyeyes@163.com

Affiliation:

Clc Number:

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    The corneal crosslinking (CXL) with riboflavin and ultraviolet-A (UVA) is a new therapy method to successfully treat infectious keratitis in clinical practice. However, there are rare reports on the complications of CXL such as the secondary keratitis. The diverse clinical outcomes on keratitis have highlighted the necessity to further evaluate the efficacy and complications of CXL. We reviewed the positive and negative reports on UVA/riboflavin related with keratitis and provided our opinion on the therapeutic and side effect of UVA/riboflavin crosslinking on keratitis.

    Reference
    Related
    Cited by
Get Citation

Liang-Zhu Jiang, Shi-Yan Qiu, Zhi-Wei Li, et al. Therapeutic and inducing effect of corneal crosslinking on infectious keratitis. Int J Ophthalmol, 2016,9(12):1820-1823

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:June 30,2015
  • Revised:August 09,2016
  • Adopted:
  • Online: December 07,2016
  • Published: